Keywords
Precision Medicine
Dust
Construction Materials
Personalized medicine
Diagnostic Imaging
Multiprotein Complexes
Family relationships
Arab countries
Lasso
Germany
Chemotherapy
Cohort Studies
Clinical trials
Alkaline Phosphatase
Survival Rate
ROC Curve
Lymphokines
Ketoconazole
Vascular Endothelial Growth Factors
Confidence Intervals
Pregnancy
Contraceptives, Oral
Receptors, Progesterone
Adenocarcinoma, Clear Cell
Population Surveillance
Disease Progression
Proportional Hazards Models
Alleles
Hispanic Americans
Translocation, Genetic
African Americans
DNA, Neoplasm
Molecular Sequence Data
DNA Primers
Age Factors
Tamoxifen
Selective Estrogen Receptor Modulators
Ribosomal Protein S6 Kinases
Cancer Vaccines
Predictive Value of Tests
Retrospective Studies
Outcome Assessment (Health Care)
Survival Analysis
Prospective Studies
Carcinoma, Renal Cell
United States
Sample Size
Clinical Trials, Phase II as Topic
Randomized Controlled Trials as Topic
Risk Assessment
Carcinoma
Treatment Failure
Factor Analysis, Statistical
Mining
Multivariate Analysis
Aged, 80 and over
Decision Making
Adenocarcinoma
Logistic Models
Kaplan-Meier Estimate
Case-Control Studies
Risk Factors
Area Under Curve
Survival
Gene Expression
Probability
Endpoint Determination
Neoplasms, Hormone-Dependent
Ovarian Neoplasms
Genotype
Genetic Predisposition to Disease
Graft vs Host Disease
Chemoprevention
Population
DNA Damage
Models, Theoretical
Sensitivity and Specificity
Gels
DNA Repair
Genes, Immunoglobulin
Statistics as Topic
Genetics, Medical
Validation Studies as Topic
Models, Biological
Efficiency, Organizational
Nomograms
Drug Design
Mutation
Equipment Design
Registries
Residence Characteristics
Reproducibility of Results
Data Interpretation, Statistical
HIV Infections
Models, Statistical
Computer Simulation
Prognosis
Tumor Markers, Biological
Disease-Free Survival
Chi-Square Distribution
Research Design
Biomarkers, Pharmacological
Urologic Neoplasms
Decision Support Techniques
Treatment Outcome
Breast Neoplasms
Biological Markers
Odds Ratio
Risk
